ReviewVirulence2026
Crosstalk between vimentin and keratins in viral infection: Implications across the viral life cycle.
Review in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intermediate filaments (IFs) have long been regarded as a static scaffold responsible for maintaining cellular structure and integrity. However, recent studies have revealed that IFs, particularly vimentin and keratin, exert a profound and versatile influence on viral infection. In this narrative review, we summarize how these IFs influence multiple stages of the viral life cycle, including attachment/entry, replication, intracellular trafficking, assembly, and egress. We further discuss their contributions to cell-to-cell spread, host immune regulation, and oncogenic processes. Collectively, these findings illustrate how viruses exploit or remodel the IF network to facilitate propagation, and highlight IF - virus interfaces as potential targets for antiviral intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.